The 2021 Women’s Venture Competition is open for applications until May 15, 2021, 11:59 PM Eastern Time.
The AIM-HI Accelerator Fund’s Women’s Venture Competition is a first-of-its-kind program that provides funding, coaching and networking opportunities to women-led oncology start-ups. The winning company of 2021 Women’s Venture Competition will receive a total of $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation.
To learn more about the Women’s Venture Competition, please click here.
News
2021 Women’s Venture Competition Announced Semi-Finalists!
The AIM-HI Accelerator Fund just announced 10 semi-finalists for the 2021 Women’s Venture Competition! These…
Applications Open for the 2021 AIM-HI Women’s Venture Competition!
Today is International Women’s Day. In honor of the occassion, the AIM-HI Accelerator Fund (AIM-HI)…
Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced
Privo Technologies to Receive $900,000 of Investment Funding Privo Technologies and its chief executive officer,…
Congratulations to our Top Two Finalists and the People’s Choice Award Winner!
Congratulations to the inaugural AIM-HI Women’s Venture Competition finalists selected by the Judging Committee, Stacy…
Our Partners & Sponsors
Privo Technologies has received investment of $900,000 – $300,000 from AIM-HI and matching investment from two supporters of the Competition! Read the press release.
Based in Peabody, Massachusetts, the company has developed a nano-engineered platform for redesigning the mechanism of action of potent cancer medicines. For more information, visit https://www.privotechnologies.com.